ALT
ALT
US02155H2004
Altimmune, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 41.000 20.000
105.0%
Cost of Revenue -- --
--
Gross Profit -- --
--
94.530.000 103.192.000
8.4%
Operating Income -94.489.000 -103.172.000
8.4%
Pretax Income -88.774.000 -95.059.000
6.6%
Net Income Common Stockholders -88.093.000 -95.059.000
7.3%
-- --
--
-- --
--
ende